Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Hernia Repair [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Exparel, bupivacaine HCl, and placebo for postoperative analgesia in hernia repair completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine hydrochloride (bupivacaine hydrochloride)
  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Analgesia, Postoperative | Phase 4 | Status: COMPLETED | Results posted: 2021-10-12